Leerink Partners on Kalvista Pharmaceuticals Inc (KALV): 'we continue to view this as a launch investors should own'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: KALV) | Delayed: 27.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.00 | 52 Week High | $ | |||
| Open | $27.00 | 52 Week Low | $ | |||
| Day High | $27.00 | P/E | N/A | |||
| Day Low | $27.00 | EPS | $ | |||
| Volume | 433 | |||||
